Cardiac receptors stand as essential components in orchestrating the intricate symphony of the cardiovascular system. These receptors function as highly sensitive signaling devices, finely tuned to respond to a spectrum of physiological cues. At the heart of cardiovascular regulation, these receptors contribute to the dynamic control of vital parameters such as heart rate, blood pressure, and cardiac contractility. Within this regulatory framework, baroreceptors emerge as key players, diligently detecting fluctuations in blood pressure and swiftly communicating this information to the central nervous system. Simultaneously, chemoreceptors intricately respond to alterations in blood composition, particularly monitoring levels of oxygen and carbon dioxide. The synergy between these distinct receptor types forms the foundation of adaptive responses, enabling the cardiovascular system to maintain equilibrium in the face of changing internal and external conditions. This nuanced understanding of cardiac receptors is pivotal in unraveling the complexities of cardiovascular dynamics, holding profound implications for advancing cardiovascular research and clinical.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation